Cite
HARVARD Citation
Boktor, M. et al. (n.d.). Substitution with Alternative Anti-TNFα Therapy (SAVANT)—Outcomes of a Crohn's Disease Cohort Undergoing Substitution Therapy with Certolizumab. Inflammatory bowel diseases. 22 (6), p. . [Online].